The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial in America that targets the less-obvious sufferers of the sexual condition: women.
Sep 30, 2014
0
0
The success of an innovative design app competition, organised through our Centre for Pain Research, is cited in a recent Parliamentary Report on advances into assistive technology that could help the elderly and people living ...
Aug 29, 2014
0
0
Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid ...
Aug 19, 2014
0
0
The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition.
Jul 9, 2014
0
0
Two California counties have filed a lawsuit accusing five drug companies of waging a campaign of deception to boost the sales of painkillers behind the nation's prescription drug addiction problem.
May 22, 2014
0
0
Many schools in England are neglecting – and may be actively harming - students' health and wellbeing, warn experts in an editorial published in BMJ today. Professor Chris Bonell at the Institute of Education and colleagues ...
May 13, 2014
0
0
A U.S. court on Wednesday invalidated the key patent for one of Pfizer's most lucrative medicines, potentially opening the door for cheaper generic versions 18 months sooner than expected and cutting into the drugmaker's ...
Mar 12, 2014
0
0
The Supreme Court will examine the North Carolina dental regulatory board's claim that only dentists should be allowed to whiten teeth.
Mar 3, 2014
0
0
Irish drugmaker Actavis PLC plans to buy Forest Laboratories Inc. for about $25 billion, catapulting little-known Actavis into the world's No. 15 drug company, with an unusual one-stop-shopping model giving it an edge: more ...
Feb 18, 2014
0
0
Swiss drug maker Novartis AG reported a 2 percent rise in fourth-quarter net profit Wednesday, helped by delays in generic competition to its blockbuster drugs.
Jan 29, 2014
0
0
